28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/
Related
The SECURE Act was enacted into law. It is effective on January 1, 2020. The Act makes significant c...
Read More >
ERISA requires Summary Plan Descriptions and other disclosures to be "written in a manner calculated...
Read More >
On Monday, September 21, 2020, the Federal Trade Commission (FTC) and Department of Justice (DOJ) jo...
Read More >
On August 22, 2019, a three-member panel of the National Labor Relations Board (NLRB) ruled unanimou...
Read More >
The U.S. Chamber of Commerce and other business organizations have filed suit in federal court again...
Read More >
It is rare for the holding in a single criminal case to have such far-reaching implications that it ...
Read More >